SEP 02, 2019 3:56 PM PDT

Treating glioblastomas through the bloodstream

New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only proven thus far in mice, the nano-immunotherapy has the potential to change the way we treat glioblastoma, the most common and aggressive form of brain cancer, forever.

New research uses nano-immunotherapy to target brain tumors via the bloodstream. Photo: Pixabay

The technology uses checkpoint inhibitor drugs in order to disarm brain tumors that fight against the immune system. But the key in this therapy is its ability to cross the blood-brain barrier – at least in mice.

"Although our findings were not made in humans," says senior study author Julia Y. Ljubimova, a professor of neurosurgery and biomedical sciences at Cedars-Sinai Medical Center in Los Angeles, CA, "they bring us closer to developing a treatment that might effectively attack brain tumors with [systemic] drug administration."

How did they do this? Well, because brain tumors suppress attack from anticancer cells using macrophages and T regulatory cells, the researchers decided to try to block them using checkpoint inhibitor drugs so that the immune system can properly activate cancer-killing cells. Using a small transporter protein to carry an inhibitor drug across the blood-brain barrier, the researchers were able to target the macrophages and T regulatory cells systemically, i.e. through the bloodstream.

Although brain cancer is not particularly common, it does account for more than its fair share of cancer deaths. According to the National Cancer Institute, 23,820 people in the United States will find out that they have brain cancer in 2019, and 17,760 will die of the disease in this same year.

While the new immunotherapy has a ways to go before it will be ready for human trials, Professor Ljubimova says, "We hope that by delivering multifunctional new-generation drugs through the blood-brain barrier, we can explore new therapies for many neurological conditions."

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job do ...
APR 06, 2020
Cancer
APR 06, 2020
Should we tell people about their cancer diagnoses?
While it might seem obvious to some cultures, sharing a patient’s diagnosis with him/her is not necessarily the no ...
MAY 02, 2020
Cancer
MAY 02, 2020
Tracking DNA Methylation as a Prognostic Marker
In the modern age of biological research, one of the tools that have become readily available in the ever-increasing dat ...
APR 29, 2020
Immunology
APR 29, 2020
New Immune Cell Discovered in Mammary Ducts
Dubbed “ductal macrophages,” newly discovered immune cells found in breast tissue offer fresh promise for fu ...
MAY 22, 2020
Cancer
MAY 22, 2020
Even minimal exercise can reduce breast cancer recurrence
New research urges individuals at high-risk of breast cancer to get moving, shaking, shimmying, and kicking! According t ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
Loading Comments...